Affymax and Takeda to Present Hematide(TM)/peginesatide Phase 2 Data at the ... - MarketWatch (press release) PDF Print
MarketWatch (press release)Hematide is an investigational agent for the treatment of anemia in chronic renal failure (also referred to as renal anemia). Affymax and investigators will

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.